Business:
Precision-designed oncolytic viral therapies
About:
Humane Genomics is a biotechnology company that is developing a platform to engineer cancer-killing viruses with unprecedented specificity and efficiency. The company was founded in 2019 by Peter Weijmarshausen, Andrew Hessel, and Chad Moles. Humane Genomics' platform uses synthetic biology to design viruses that are specifically targeted to cancer cells. The company's viruses are designed to be more effective and less toxic than traditional cancer treatments, such as chemotherapy and radiation therapy. Humane Genomics is currently developing its platform for the treatment of liver cancer.